Literature DB >> 7108513

The binding of [3H]-5-hydroxytryptamine to homogenates of human brain.

E Dehlin, J Marcusson, C J Fowler, B Winblad.   

Abstract

The binding of [3H]-5-hydroxytryptamine ([3H]-5-HT) to homogenates of human brain has been studied. The specific binding is saturable, with a Kd (frontal cortex) of 12 /+- 2 nM, and is inhibited by non-radioactive 5-HT (IC50=26 nM) and D-Lysergic acid diethylamide (IC50=20 nM). Specific, but not non-specific binding of [3H]-5-TH was inhibited by incubation of the homogenates at 50 degrees C. The binding of [3H]-5-HT across the human brain was not uniform, the highest binding being found in the substantia nigra and hippocampus, and the lowest in the thalamus and pons. The Kd of the binding sites towards 5-HT did, however, appear to be similar for the different brain regions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7108513     DOI: 10.1007/BF01249282

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  32 in total

1.  Huntington's chorea. Changes in neurotransmitter receptors in the brain.

Authors:  S J Enna; E D Bird; J P Bennett; D B Bylund; H I Yamamura; L L Iversen; S H Snyder
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

2.  Evaluation of a semiautomatic filtration technique for receptor binding studies.

Authors:  H Hall; L Thor
Journal:  Life Sci       Date:  1979-06-11       Impact factor: 5.037

3.  The inhibition or rat heart type A monoamine oxidase by clorgyline as a method for the estimation of enzyme active centers.

Authors:  C J Fowler; B A Callingham
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

4.  Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.

Authors:  D L Nelson; A Herbet; S Bourgoin; J Glowinski; M Hamon
Journal:  Mol Pharmacol       Date:  1978-11       Impact factor: 4.436

5.  Serotonin binding to different regions of human brain.

Authors:  J A Heltzel; D H Boehme; W H Vogel
Journal:  Brain Res       Date:  1981-01-12       Impact factor: 3.252

6.  Serotonin receptor concentration during the estrous cycle of the rat.

Authors:  A Biegon; H Bercovitz; D Samuel
Journal:  Brain Res       Date:  1980-04-07       Impact factor: 3.252

7.  Increased central 5-hydroxytryptamine receptor mechanisms in rats after chronic neuroleptic treatment.

Authors:  D Dawbarn; S K Long; C J Pycock
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

8.  Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.

Authors:  D D Savage; J Mendels; A Frazer
Journal:  J Pharmacol Exp Ther       Date:  1980-02       Impact factor: 4.030

9.  Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--I.

Authors:  D L Nelson; A Herbet; A Enjalbert; J Bockaert; M Hamon
Journal:  Biochem Pharmacol       Date:  1980-09-15       Impact factor: 5.858

10.  Titration of human brain monoamine oxidase -A and -B by clorgyline and L-deprenil.

Authors:  C J Fowler; L Oreland; J Marcusson; B Winblad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

View more
  1 in total

1.  Serotonin binding in mouse brains. Some methodological aspects.

Authors:  J Marcusson; L Oreland; B Winblad
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.